English name | Umeclidinium Bromide 乌美溴铵 |
Synonyms | DIPHENYL-[1-(2-PHENYLMETHOXYETHYL)-1-AZONIABICYCLO[2.2.2]OCTAN-4-YL]METHANOL;BROMIDE;CS-1562;Umeclidiniumbromide(GSK573719A);1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmChemicalbookethyl)-1-quinuclidiniumBromide;Umeclinidiumbromide;GSK573719A;GSK-573719A;GSK573719A;1-(2-(benzyloxy)ethyl)-4-(hydroxydiphenylmethyl)quinuclidin-1-iumbromide;GSK573719A |
CAS | 869113-09-7 |
EINECS | 638-761-1 |
Molecular formula | C29H34BrNO2 |
Molecular weight | 508.48976 |
Melting point | >231°C (dec.) |
Solubility | DMSO (Slightly), Methanol (Slightly), Water (Slightly) |
Storage condition | under inert gas (nitrogen or Argon) at 2-8°C |
Appearance | Solid |
Colour | White to Off-White |
Use | It is a long-acting, competitive and reversible carinic choline receptor antagonist (mAChRs) that maintains bronchiectasis. The drug is used to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). |
